Collaborative Referral Model for Hepatitis C Screening and Treatment in a Remote Mountainous Region of Taiwan during the COVID-19 Pandemic
Viruses · 2023
DOI: 10.3390/v15040827 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Chi-Ming Tai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Internal Medicine, E-Da Hospital, I-Shou University, Kaohsiung 824, Taiwan. Hauptthemen laut MEDLINE: Hepatitis C, Chronic, COVID-19, Hepatitis C. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: E-Da Hospital.
Abstract (Originalsprache)
Community-based screening for the hepatitis C virus (HCV) decreased during the COVID-19 pandemic. We developed a collaborative referral model between a primary clinic (Liouguei District Public Health Center, LDPHC) and a tertiary referral center to increase HCV screening and treatment uptake in a mountainous region of Taiwan. Once-in-a-lifetime hepatitis B and C screening services established by the Taiwan National Health Insurance were performed at LDPHC. Antibody-to-HCV (anti-HCV)-seropositive patients received scheduled referrals and took a shuttle bus to E-Da hospital for HCV RNA testing on their first visit. Direct-acting antiviral agents (DAAs) were prescribed for HCV-viremic patients on their second visit. From October 2020 to September 2022, of 3835 residents eligible for HCV screening in Liouguei District, 1879 (49%) received anti-HCV testing at LDPHC. The overall HCV screening coverage rate increased from 40% before referral to 69.4% after referral. Of the 79 anti-HCV-seropositive patients, 70 (88.6%) were successfully referred. Of the 38 HCV-viremic patients, 35 (92.1%) received DAA therapy, and 32 (91.4%) achieved sustained virological response. The collaborative referral model demonstrates a good model for HCV screening and access to care and treatment in a Taiwan mountainous region, even during the COVID-19 pandemic. Sustained referral is possible using this routine referral model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, E-Da Hospital, I-Shou University, Kaohsiung 824, Taiwan.
- School of Medicine for International Students, College of Medicine, I-Shou University, Kaohsiung 824, Taiwan.
- Division of Gastroenterology, Department of Internal Medicine, Taitung Mackay Memorial Hospital, Taitung 950408, Taiwan.
- Department of Medicine, Mackay Medical College, New Taipei 252, Taiwan.
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, E-Da Cancer Hospital, I-Shou University, Kaohsiung 824, Taiwan.
- School of Medicine, College of Medicine, I-Shou University, Kaohsiung 824, Taiwan.
ORCID-Profile: Chi-Ming Tai, Ming-Lung Yu
Förderung
- E-Da Hospital
Zitieren
APA
Tai, C. M., Bair, M. J., Chen, T. H., Tseng, C. H., Chen, C. C., Lam, H., & Yu, M. L. (2023). Collaborative Referral Model for Hepatitis C Screening and Treatment in a Remote Mountainous Region of Taiwan during the COVID-19 Pandemic. Viruses. https://doi.org/10.3390/v15040827
Vancouver
Tai CM, Bair MJ, Chen TH, Tseng CH, Chen CC, Lam H, et al. Collaborative Referral Model for Hepatitis C Screening and Treatment in a Remote Mountainous Region of Taiwan during the COVID-19 Pandemic. Viruses. 2023. doi:10.3390/v15040827
BibTeX
@article{Tai2023,
author = {Tai, Chi-Ming and Bair, Ming-Jong and Chen, Tzu-Haw and Tseng, Cheng-Hao and Chen, Chih-Cheng and Lam, Hung and Yu, Ming-Lung},
title = {Collaborative Referral Model for Hepatitis C Screening and Treatment in a Remote Mountainous Region of Taiwan during the COVID-19 Pandemic},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15040827}
}
EUVIMED